Avails Medical, Inc.

MENLO PARK, CA · Founded 2013 · Medtech · Private

Silicon nanowire field-effect transistor (SiNW-ISFET) device for rapid bacterial detection and antibiotic susceptibility testing in urine samples

Claim this profile

Follows are private to you and power your alerts

Updated · availsmedical.com

Sector
Medtech
Headquarters
MENLO PARK, CA
Founded
2013
Latest Form D
$6.4M, Feb 2017
Total capital
$7.9M
Federal grants
$225K
1 award · 2016
Rank in peer group#287 of 542
Private capital raised
$7.7M
4 Form D · last Feb 2017
117 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
27
13 pending · first 2016
Rank in peer group#8 of 542

Capital timeline

2014201520162017FEDERAL ↑EQUITY ↓Cumulative $7.9M$225K1st Form D$250K2nd Form D$550K4th Form D$6.4M
2014201520162017FEDERAL ↑EQUITY ↓Cumulative $7.9M$225K2nd Form D$550K4th Form D$6.4M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$6.4M
  • Private capital raisedForm D · SEC · 3rd filing$500K
  • Federal grantHealth and Human S · Phase I · Electrical Biosensor for Rapid Point-of-Care Diagnosis of Urinary Tract Infections and Antibiotic Susceptibility Testing$225K
  • Private capital raisedForm D · SEC · 2nd filing$550K
  • Private capital raisedForm D · SEC · 1st filing$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#8 · top 1%
  • Linked publications#12 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Oren KnopfmacherResearcherExecutive Officer, DirectorLinked by 6 patents
  • Aaron BerezDirectorNamed in SEC Form D filings
  • Michael LauferDirectorNamed in SEC Form D filings
  • Nancy IsaacDirectorNamed in SEC Form D filings

What it has protected

USPTO · 27 granted of 40
Show all 40 patent records

Recent research by its founders

  • Multicenter evaluation of the eQUANT system for use with disk diffusion AST of gram-negative bacteria directly from positive blood cultures20251 cites
  • Pilot study evaluation of the eQUANT™ system for accelerated antimicrobial susceptibility testing of gram-negative organisms directly from positive blood cultures20242 cites
  • Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing20214 cites
  • HEMEX HEALTH INCSimilar federal contract value in Medtech · null in contracts
  • Spinethera, Inc.Similar federal contract value in Medtech · null in contracts
  • IKONISYS INCSimilar federal contract value in Medtech · null in contracts
  • KINEOLABS, INC.Similar federal contract value in Medtech · null in contracts
  • NONINVASIX, INC.Similar federal contract value in Medtech · null in contracts
  • Cure Pharmaceutical Holding Corp.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .